Author

Laurent Peyrin-Biroulet 1

1 CHU Nancy

: THERAPEUTIC DRUG MONITORING OF INFLIXIMAB AND MUCOSAL HEALING IN INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE STUDY

Stéphane Paul, hubert marotte, Emilie Del Tedesco, Laurent Peyrin-Biroulet, Xavier Roblin

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

Fernando Gomollon Garcia, Axel Dignass, Vito Annese, Herbert Tilg, Gert Van Assche, James Lindsay, Laurent Peyrin-Biroulet, Garret Cullen, Marco Daperno, Torsten Kucharzik, Florian Rieder, Sven Almer, Alessandro Armuzzi, Marcus Harbord, Jost Langhorst, Miquel Sans, Yehuda Chowers, Gionata Fiorino, Pascal Juillerat, Geras

A MULTINATIONAL STUDY TO DETERMINE INDICATORS OF SUBOPTIMAL THERAPY AMONG ULCERATIVE COLITIS PATIENTS TREATED WITH TUMOR NECROSIS FACTOR ANTAGONISTS

James Lindsay, Javier Gisbert, Reema Mody, Laurent Peyrin-Biroulet, Alessandro Armuzzi, Bernd Bokemeyer, Geoffrey C. Nguyen, Jean Siebenaler, Örjan Åkerborg, Michael Smyth

A NOVEL SIMPLE SCORE FOR THE DIAGNOSIS OF CROHN’S DISEASE

Sieglinde Reinisch, Karin Schweiger, Eleonore Pablik, Benjamin Collet-Fenetrier, Laurent Peyrin-Biroulet, Julian Panés, Walter Reinisch

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF A SELECTIVE, ORAL SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, ETRASIMOD (APD334), IN MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE OASIS STUDY

William Sandborn, Laurent Peyrin-Biroulet, Luba Trokan, Jinkun Zhang, Tanja Kühbacher, Michael Chiorean, Scott D. Lee, Severine Vermeire, Bruce Yacyshyn, Snehal U. Naik, Preston Klassen, Julian Panés

AbbVie - Are we ready to change the course of IBD?

Edouard Louis, Remo Panaccione, Laurent Peyrin-Biroulet, Jean-Frederic Colombel

ACUTE INFUSION REACTIONS UNDER VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS: RESULTS OF A MULTICENTER RETROSPECTIVE OBSERVATIONAL COHORT STUDY

chloé Venturin, Stéphane Nancey, Xavier Roblin, Laurent Peyrin-Biroulet, Nicolas Mathieu, Claire Gay, Pauline Danion, Remi Duclaux-Loras, Camille Meunier, Bernard Flourie, Gilles Boschetti

Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre prospective, observational cohort study

Guillaume Pineton de Chambrun, Benjamin Pariente, Philippe Seksik, Romain Altwegg, Lucine Vuitton, Carmen Stefanescu, Stéphane Nancey, Alexandre Aubourg, Mélanie Serrero, Laurent Peyrin-Biroulet, Jerome Filippi, Stéphanie Viennot, Vered Abitbol, Medina Boualit, Arnaud Bourreille, Maria Nachury, Jacques Moreau, Anthony Buis

AN EXPERT CONSENSUS TO STANDARDIZE THE ASSESSMENT OF HISTOLOGIC DISEASE ACTIVITY IN CROHN'S DISEASE CLINICAL TRIALS

Ahmed Almradi, Christopher Ma, Geert R. D'Haens, William Sandborn, Claire Parker, Leonardo Guizzetti, Paula Borralho Nunes, Geert De Hertogh, Roger M. Feakins, Reena Khanna, Gregory Y. Lauwers, Aart Mookhoek, Reet Pai, Laurent Peyrin-Biroulet, Robert Riddell, Christophe Rosty, David F. Schaeffer, Mark Valasek, Brian G. Fe

AN INTRODUCTION TO LUCID; LIVING WITH ULCERATIVE COLITIS; IDENTIFYING THE SOCIOECONOMIC BURDEN IN EUROPE

Alison Rose, Alan J Lobo, Saida Abounit, Luisa Avedano, Laurent Peyrin-Biroulet, Johan Burisch, Gionata Fiorino, Bu Hayee, Jimmy K. Limdi, Andreas Sturm, Helen Terry, Seb Tucknott, Alan Finnegan, Rosa Willock

Item 1 - 10 / 184
1
2 3 4 5 6 7
...
18 19